Dr. Andrea Ambrosini-Spaltro | Oncology, Otorhinolaryngology | Best Researcher Award

Andrea Ambrosini Spaltro is a distinguished pathologist with extensive expertise in anatomic pathology. His career spans multiple prestigious institutions, where he has contributed significantly to medical research and diagnostics. His work focuses on pulmonary pathology, head and neck pathology, and dermatopathology, making him a key figure in advancing the understanding of complex diseases.

Profile

ORCID

Education

Andrea pursued his medical degree at the University of Bologna, Italy, graduating with honors in 2003. He specialized in anatomic pathology, completing his residency in 2008, followed by a Ph.D. in Experimental Oncology in 2012. His academic journey has been marked by rigorous research and contributions to the field of pathology, particularly in immunohistochemical and molecular prognostic markers.

Experience

Andrea has held various positions across Italy’s leading medical institutions. His professional journey began at the University Hospital of Parma, followed by roles at Central Bolzano Hospital and Modena Policlinico. Since 2019, he has been a staff member at Morgagni-Pierantoni Hospital, AUSL Romagna, Forlì, Italy. His experience encompasses diagnostic pathology, research, and mentorship, shaping the next generation of medical professionals.

Research Interest

His research interests lie in pulmonary pathology, head and neck pathology, and dermatopathology. He has explored oncocytic modifications in rectal adenocarcinomas, neurothekeoma, and plexiform fibrohistiocytic tumors, among other topics. His work integrates molecular diagnostics with traditional pathology, enhancing precision medicine approaches.

Award

Andrea has been recognized for his contributions to pathology through various accolades and memberships in esteemed medical societies, including the Italian Society of Anatomic Pathology (SIAPeC) and the European Society of Pathology (ESP). His involvement in international collaborations and editorial roles further underscores his impact on the field.

Publications

1. Oncocytic modifications in rectal adenocarcinomas after radio and chemotherapy (2006) – Published in Virchows Arch, cited in multiple studies on rectal cancer treatment.
2. Carcinosarcoma of the colon: morphological, ultrastructural, and molecular analysis (2006) – Published in BMC Cancer, referenced in colorectal cancer research.
3. High MUC2 immunohistochemical expression as a predictor of poor response to preoperative radiochemotherapy in rectal adenocarcinoma (2008) – Published in Appl Immunohistochem Mol Morphol, cited in studies on tumor markers.
4. Pancreatic-type acinar cell carcinoma of the stomach beneath a focus of pancreatic metaplasia (2009) – Published in Hum Pathol, contributing to gastrointestinal cancer literature.
5. Nasal seromucinous hamartoma: a morphological and molecular study (2010) – Published in Virchows Arch, cited in nasal tumor research.
6. IGFBP2 as an immunohistochemical marker for prostatic adenocarcinoma (2011) – Published in Appl Immunohistochem Mol Morphol, referenced in prostate cancer diagnostics.
7. EGFR mutation-specific antibodies in pulmonary adenocarcinoma: a comparison with DNA direct sequencing (2012) – Published in Appl Immunohistochem Mol Morphol, cited in lung cancer studies.

Conclusion

Andrea Ambrosini Spaltro’s career is a testament to his dedication to pathology and medical research. His contributions to diagnostic advancements, molecular pathology, and education have left a lasting impact on the field. His work continues to shape the understanding of complex diseases, making him a respected figure in pathology.